NCT01496820View on ClinicalTrials.gov

A Randomized Trial to Assess the Efficacy and Safety of GO2KA1(Chitosan Oligosaccharide)on Blood Glucose Control

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

December 31, 2012

Conditions
Impaired Fasting Glucose, Newly-diagnosed Type 2 Diabetes
Interventions
DIETARY_SUPPLEMENT

GO2KA1

GO2KA1(chitosan oligosaccharide)1500mg/day for 12weeks

DIETARY_SUPPLEMENT

Placebo

placebo 1500mg/day for 12weeks

Trial Locations (1)

120-749

Yonsei University, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01496820 - A Randomized Trial to Assess the Efficacy and Safety of GO2KA1(Chitosan Oligosaccharide)on Blood Glucose Control | Biotech Hunter | Biotech Hunter